We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

92 hedge funds and large institutions have $585M invested in Abeona Therapeutics in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more call options, than puts

Call options by funds: $9.11M | Put options by funds: $4.3M

68% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 22

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

24% more capital invested

Capital invested by funds: $471M → $585M (+$114M)

5% more funds holding

Funds holding: 88 → 92 (+4)

0.31% more ownership

Funds ownership: 2.78% → 3.09% (+0.31%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
92
Holders Change
+4
Holders Change %
+4.55%
% of All Funds
2.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
37
Reduced
22
Closed
12
Calls
$9.11M
Puts
$4.3M
Net Calls
+$4.81M
Net Calls Change
+$1.78M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$42.2M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$40M
3
State Street
State Street
Massachusetts
+$11.4M
4
PC
PointState Capital
New York
+$10.1M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$6.96M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$27.9M
2
PA
Perceptive Advisors
New York
-$16.4M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$11.9M
4
HCM
Highbridge Capital Management
New York
-$6.1M
5
UBS Group
UBS Group
Switzerland
-$2.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
$1.5M +$194K +445 +13%
Bank of America
27
Bank of America
North Carolina
$1.49M +$1.37M +3,141 +547%
TD Asset Management
28
TD Asset Management
Ontario, Canada
$1.31M +$860K +1,968 +151%
TCIM
29
TIAA CREF Investment Management
New York
$1.05M -$23.2K -53 -2%
CT
30
Cambridge Trust
Massachusetts
$1.05M – – –
AS
31
Altshuler Shaham
Israel
$1.02M +$467K +1,068 +72%
Charles Schwab
32
Charles Schwab
California
$1.01M – – –
Alkeon Capital Management
33
Alkeon Capital Management
New York
$984K +$437K +1,000 +68%
PA
34
Perceptive Advisors
New York
$954K -$16.4M -37,540 -94%
BGIM
35
Brandywine Global Investment Management
Pennsylvania
$918K -$26.7K -61 -3%
TA
36
Teachers Advisors
New York
$895K +$78.2K +179 +9%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$888K +$530K +1,212 +120%
VEA
38
Virtus ETF Advisers
New York
$817K +$68.2K +156 +8%
Swiss National Bank
39
Swiss National Bank
Switzerland
$802K – – –
Wells Fargo
40
Wells Fargo
California
$773K +$29.3K +67 +4%
AllianceBernstein
41
AllianceBernstein
Tennessee
$773K +$75.2K +172 +10%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$755K +$76K +174 +10%
AQR Capital Management
43
AQR Capital Management
Connecticut
$588K -$80.4K -184 -11%
CS
44
Credit Suisse
Switzerland
$579K +$22.7K +52 +4%
Citadel Advisors
45
Citadel Advisors
Florida
$536K -$27.9M -63,897 -98%
HP
46
Hikari Power
Japan
$530K +$579K +1,324 New
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$528K +$83.9K +192 +17%
CIM
48
CIM Investment Management
Pennsylvania
$517K – – –
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$476K +$30.6K +70 +6%
Principal Financial Group
50
Principal Financial Group
Iowa
$419K +$173K +395 +60%
1
2
3 4 5

ABEO Hedge Fund Activity: Q2 2018 in Review

92 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q2 2018, worth a combined $585M — up 24% from $471M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ABEO positions and 12 closed out — a net gain of 4 holders — while 37 added to existing stakes and 22 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $42.2M. The largest seller was Citadel Advisors, cutting an estimated $27.9M.

  • 92 institutional investors held Abeona Therapeutics (ABEO) as of Q2 2018, up from 88 in Q1 2018.
  • Funds reported $585M of Abeona Therapeutics stock for Q2 2018, up 24% quarter-over-quarter.
  • 16 funds opened new Abeona Therapeutics positions in Q2 2018 and 12 closed out, a net change of +4 holders.
  • The largest Abeona Therapeutics buyer in Q2 2018 was T. Rowe Price Associates, an estimated $42.2M added.
  • The largest Abeona Therapeutics seller in Q2 2018 was Citadel Advisors, an estimated $27.9M sold.

Based on aggregated 13F filings for Q2 2018.